Advanced search
Publication Cover
Clinical Interventions in Aging Volume 10, 2015 - Issue
Submit an article Journal homepage
736
Views
159
CrossRef citations to date
0
Altmetric
Review

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment

Xiaohua Li1 Dalian Medical University, Dalian, People’s Republic of China
,
Dalin Song2 Department of Geriatrics, Qingdao Municipal Hospital, Qingdao, People’s Republic of ChinaCorrespondence[email protected]
&
Sean X Leng3 Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Pages 549-560 | Published online: 10 Mar 2015

Citations (159)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Hoda E. Mohamed, Mervat E. Asker, Nahla N. Younis, Mohamed A. Shaheen & Rana G. Eissa. (2020) Modulation of brain insulin signaling in Alzheimer’s disease: New insight on the protective role of green coffee bean extract. Nutritional Neuroscience 23:1, pages 27-36.
Read now
Shuangling Xiu, Zheng Zheng, Qiuju Liao & Piu Chan. (2019) Different risk factors for cognitive impairment among community-dwelling elderly, with impaired fasting glucose or diabetes. Diabetes, Metabolic Syndrome and Obesity 12, pages 121-130.
Read now
Pailla Umareddy & Veera Reddy Arava. (2019) Facile synthesis of 3-aryl benzofurans, 3-aryl benzothiophenes, 2-aryl indoles and their dimers. Synthetic Communications 49:17, pages 2156-2167.
Read now
Anne-Claire Dorsemans, David Couret, Anaïs Hoarau, Olivier Meilhac, Christian Lefebvre d'Hellencourt & Nicolas Diotel. (2017) Diabetes, adult neurogenesis and brain remodeling: New insights from rodent and zebrafish models. Neurogenesis 4:1.
Read now
Olga Pivovarova, Annika Höhn, Tilman Grune, Andreas F.H. Pfeiffer & Natalia Rudovich. (2016) Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer’s disease?. Annals of Medicine 48:8, pages 614-624.
Read now
Sevilay Muratli, Fatih Tufan, Ozlem Soyluk, Gulistan Bahat & M Akif Karan. (2015) Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus. Clinical Interventions in Aging 10, pages 1789-1791.
Read now

Articles from other publishers (153)

Alev Duygu Acun, Deniz Kantar, Hakan Er, Orhan Erkan, Narin Derin & Piraye Yargıcoglu. (2023) Investigation of Cyclo-Z Therapeutic Effect on Insulin Pathway in Alzheimer's Rat Model: Biochemical and Electrophysiological Parameters. Molecular Neurobiology 60:7, pages 4030-4048.
Crossref
Z.J. Franklin, L. Croce, R. Dekeryte, M. Delibegovic & B. Platt. (2023) BACE cleavage of APP does not drive the diabetic phenotype of PLB4 mice. Neurobiology of Disease 182, pages 106142.
Crossref
Yujiao Li, Jun Chang, Xi Chen, Jianwei Liu & Lan Zhao. (2023) Advances in the Study of APOE and Innate Immunity in Alzheimer’s Disease. Journal of Alzheimer's Disease, pages 1-16.
Crossref
Priyadarshi Prajjwal, Mohammed Dheyaa Marsool Marsool, Pugazhendi Inban, Bhavya Sharma, Shahnaz Asharaf, Soumya Aleti, Srikanth Gadam, Ahmed Sermed Al Sakini & Dalia Dhia Hadi. (2023) Vascular dementia subtypes, pathophysiology, genetics, neuroimaging, biomarkers, and treatment updates along with its association with Alzheimer's dementia and diabetes mellitus. Disease-a-Month 69:5, pages 101557.
Crossref
Kuang-Hua Huang, Ya-Fang Tsai, Chiachi Bonnie Lee, Shuo-Yan Gau, Tung-Han Tsai, Ning-Jen Chung & Chien-Ying Lee. (2023) The Correlation between Metformin Use and Incident Dementia in Patients with New-Onset Diabetes Mellitus: A Population-Based Study. Journal of Personalized Medicine 13:5, pages 738.
Crossref
Iwona Piątkowska-Chmiel, Mariola Herbet, Monika Gawrońska-Grzywacz, Kamil Pawłowski, Marta Ostrowska-Leśko & Jarosław Dudka. (2023) Molecular and neural roles of sodium-glucose cotransporter 2 inhibitors in alleviating neurocognitive impairment in diabetic mice. Psychopharmacology 240:4, pages 983-1000.
Crossref
Manisha Vohra, Mohammad Amir, Amit Sharma & Sheetu Wadhwa. (2023) Formulation strategies for nose-to-brain drug delivery in Alzheimer's disease. Health Sciences Review 6, pages 100075.
Crossref
Erika Richter, Thangiah Geetha, Donna Burnett, Tom L. Broderick & Jeganathan Ramesh Babu. (2023) The Effects of Momordica charantia on Type 2 Diabetes Mellitus and Alzheimer’s Disease. International Journal of Molecular Sciences 24:5, pages 4643.
Crossref
Amaia Ezkurdia, María J. Ramírez & Maite Solas. (2023) Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance. International Journal of Molecular Sciences 24:5, pages 4354.
Crossref
Anne-Cathrine S. Vogt, Gary T. Jennings, Mona O. Mohsen, Monique Vogel & Martin F. Bachmann. (2023) Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β. International Journal of Molecular Sciences 24:4, pages 3895.
Crossref
Ricardo Castillo-Velázquez, Flavio Martínez-Morales, Julio E. Castañeda-Delgado, Mariana H. García-Hernández, Verónica Herrera-Mayorga, Francisco A. Paredes-Sánchez, Gildardo Rivera, Bruno Rivas-Santiago & Edgar E. Lara-Ramírez. (2023) Bioinformatic prediction of the molecular links between Alzheimer’s disease and diabetes mellitus. PeerJ 11, pages e14738.
Crossref
Archana Arjunan, Dhiraj Kumar Sah, Minna Woo & Juhyun Song. (2023) Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome. Cell & Bioscience 13:1.
Crossref
Temiloluwa Adebola Arowosola, Oyenike Omolola Makanjuola & Olusola Fatimah Olagunju-Yusuf. 2023. Food Security and Safety Volume 2. Food Security and Safety Volume 2 59 81 .
Timothy M. Hughes, Samuel N. Lockhart, Cynthia K. Suerken, Youngkyoo Jung, Christopher T. Whitlow, James R. Bateman, Benjamin J. Williams, Mark A. Espeland, Bonnie C. Sachs, Jeff Williamson, Maryjo Cleveland, Mia Yang, Samantha Rogers, Kathleen M. Hayden, Laura D. Baker & Suzanne Craft. (2022) Hypertensive Aspects of Cardiometabolic Disorders Are Associated with Lower Brain Microstructure, Perfusion, and Cognition. Journal of Alzheimer's Disease 90:4, pages 1589-1599.
Crossref
Rim Hamzé, Etienne Delangre, Stefania Tolu, Manon Moreau, Nathalie Janel, Danielle Bailbé & Jamileh Movassat. (2022) Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets. International Journal of Molecular Sciences 23:23, pages 15287.
Crossref
Mohammed Al‐Onaizi, Ahmad Al‐Sarraf, Kawthar Braysh, Fatema Kazem, Heba Al‐Hussaini, Muddanna Rao, Narayana Kilarkaje & Ayman ElAli. (2022) Impaired spatial navigation and age‐dependent hippocampal synaptic dysfunction are associated with chronic inflammatory response in db/db mice. European Journal of Neuroscience 56:11, pages 6003-6021.
Crossref
Haiyang Du, Xiaoyu Meng, Yu Yao & Jun Xu. (2022) The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease. Frontiers in Endocrinology 13.
Crossref
Giuseppe Pasqualetti, Tony Thayanandan & Paul Edison. (2022) Influence of genetic and cardiometabolic risk factors in Alzheimer’s disease. Ageing Research Reviews 81, pages 101723.
Crossref
Ryogo Shobatake, Hiroyo Ota, Nobuyuki Takahashi, Satoshi Ueno, Kazuma Sugie & Shin Takasawa. (2022) The Impact of Intermittent Hypoxia on Metabolism and Cognition. International Journal of Molecular Sciences 23:21, pages 12957.
Crossref
Rachel R. Corrigan, Helen Piontkivska & Gemma Casadesus. (2022) Amylin Pharmacology in Alzheimer’s Disease Pathogenesis and Treatment. Current Neuropharmacology 20:10, pages 1894-1907.
Crossref
Kellyann Niotis, Kiarra Akiyoshi, Caroline Carlton & Richard Isaacson. (2022) Dementia Prevention in Clinical Practice. Seminars in Neurology 42:05, pages 525-548.
Crossref
Guojun Liu, Yong Li, Yuzhen Xu & Wei Li. (2022) Type 2 diabetes is associated with increased risk of dementia, but not mild cognitive impairment: a cross-sectional study among the elderly in Chinese communities. Frontiers in Aging Neuroscience 14.
Crossref
Jinho Kim, ShinWoo Kang & Keun-A Chang. (2022) Effect of cx-DHED on Abnormal Glucose Transporter Expression Induced by AD Pathologies in the 5xFAD Mouse Model. International Journal of Molecular Sciences 23:18, pages 10602.
Crossref
Wajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, Suzanne L Tyas, Iliana C Lega & John-Michael Gamble. (2022) Hypoglycaemia and the risk of dementia: a population-based cohort study using exposure density sampling. International Journal of Epidemiology.
Crossref
Chutikorn Nopparat, Worawut Chaopae, Parichart Boontem, Pattarawut Sopha, Prapimpun Wongchitrat & Piyarat Govitrapong. (2021) Melatonin Attenuates High Glucose-Induced Changes in Beta Amyloid Precursor Protein Processing in Human Neuroblastoma Cells. Neurochemical Research 47:9, pages 2568-2579.
Crossref
Vijay Kumar, So-Hyeon Kim & Kausik Bishayee. (2022) Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions. International Journal of Molecular Sciences 23:17, pages 9540.
Crossref
Justin P. Ma, Cason B. Robbins, Jia Min Lee, Srinath Soundararajan, Sandra S. Stinnett, Rupesh Agrawal, Brenda L. Plassman, Eleonora M. Lad, Heather Whitson, Dilraj S. Grewal & Sharon Fekrat. (2022) Longitudinal Analysis of the Retina and Choroid in Cognitively Normal Individuals at Higher Genetic Risk of Alzheimer Disease. Ophthalmology Retina 6:7, pages 607-619.
Crossref
Bhaswati Roy, Alba Nunez, Ravi S. Aysola, Daniel W. Kang, Susana Vacas & Rajesh Kumar. (2022) Impaired Glymphatic System Actions in Obstructive Sleep Apnea Adults. Frontiers in Neuroscience 16.
Crossref
Georgina Torrandell-Haro, Gregory L. Branigan, Roberta Diaz Brinton & Kathleen E. Rodgers. (2022) Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer’s Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients. Frontiers in Aging Neuroscience 14.
Crossref
Jinyu Wang, Luxin Zhang, Hao Cao, Xinyi Shi, Xiaorong Zhang, Zihao Gao, Katsumi Ikeda, Tingxu Yan, Ying Jia & Fanxing Xu. (2022) Silibinin improves L-cell mass and function through an estrogen receptor-mediated antioxidative mechanism. Phytomedicine 99, pages 154022.
Crossref
Walaa Fakih, Ralph Zeitoun, Ibrahim AlZaim, Ali H. Eid, Firas Kobeissy, Khaled S. Abd‐Elrahman & Ahmed F. El‐Yazbi. (2022) Early metabolic impairment as a contributor to neurodegenerative disease: Mechanisms and potential pharmacological intervention. Obesity 30:5, pages 982-993.
Crossref
Genaro G Ortiz, Miguel Huerta, Héctor A González-Usigli, Erandis D Torres-Sánchez, Daniela LC Delgado-Lara, Fermín P Pacheco-Moisés, Mario A Mireles-Ramírez, Blanca MG Torres-Mendoza, Roxana I Moreno-Cih & Irma E Velázquez-Brizuela. (2022) Cognitive disorder and dementia in type 2 diabetes mellitus. World Journal of Diabetes 13:4, pages 319-337.
Crossref
Reshma Mary Martiz, Shashank M. Patil, Mohammed Abdulaziz, Ahmed Babalghith, Mahmoud Al-Areefi, Mohammed Al-Ghorbani, Jayanthi Mallappa Kumar, Ashwini Prasad, Nagendra Prasad Mysore Nagalingaswamy & Ramith Ramu. (2022) Defining the Role of Isoeugenol from Ocimum tenuiflorum against Diabetes Mellitus-Linked Alzheimer’s Disease through Network Pharmacology and Computational Methods. Molecules 27:8, pages 2398.
Crossref
Manish Kumar & Nitin Bansal. (2022) A Revisit to Etiopathogenesis and Therapeutic Strategies in Alzheimer’s Disease. Current Drug Targets 23:5, pages 486-512.
Crossref
Shen Ning, Mehdi Jorfi, Shaun R. Patel, Doo Yeon Kim & Rudolph E. Tanzi. (2022) Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s Disease. Frontiers in Neuroscience 16.
Crossref
Hussein N. Yassine, Victoria Solomon, Angad Thakral, Nasim Sheikh‐Bahaei, Helena C. Chui, Meredith N. Braskie, Lon. S. Schneider & Konrad Talbot. (2021) Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon‐like peptide‐1 receptor agonists. Alzheimer's & Dementia 18:3, pages 478-497.
Crossref
Rahnuma Ahmad, Kona Chowdhury, Santosh Kumar, Mohammed Irfan, Govindool Reddy, Farhana Akter, Dilshad Jahan & Mainul Haque. (2022) Diabetes Mellitus: A Path to Amnesia, Personality, and Behavior Change. Biology 11:3, pages 382.
Crossref
Giuseppe Fanelli, Barbara Franke, Ward De Witte, I. Hyun Ruisch, Jan Haavik, Veerle van Gils, Willemijn J. Jansen, Stephanie J. B. Vos, Lars Lind, Jan K. Buitelaar, Tobias Banaschewski, Søren Dalsgaard, Alessandro Serretti, Nina Roth Mota, Geert Poelmans & Janita Bralten. (2022) Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders. Translational Psychiatry 12:1.
Crossref
Yijing Tang, Dong Zhang, Xiong Gong & Jie Zheng. (2022) A mechanistic survey of Alzheimer's disease. Biophysical Chemistry 281, pages 106735.
Crossref
Komal Jabeen, Kanwal Rehman & Muhammad Sajid Hamid Akash. (2021) Genetic mutations of APOEε4 carriers in cardiovascular patients lead to the development of insulin resistance and risk of Alzheimer's disease. Journal of Biochemical and Molecular Toxicology 36:2.
Crossref
Ancuta-Veronica Lupaescu, Monica Iavorschi & Mihai Covasa. (2022) The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer’s Disease. Pharmaceutics 14:2, pages 235.
Crossref
Matthieu Lilamand, François Mouton-Liger, Emmanuelle Di Valentin, Marta Sànchez Ortiz & Claire Paquet. (2022) Efficacy and Safety of Ketone Supplementation or Ketogenic Diets for Alzheimer's Disease: A Mini Review. Frontiers in Nutrition 8.
Crossref
Kaushik Ravipati, Yunxiao Chen & Joseph R. Manns. (2022) Reassessing Diabetes and APOE Genotype as Potential Interacting Risk Factors for Alzheimer’s Disease. American Journal of Alzheimer's Disease & Other Dementias® 37, pages 153331752110709.
Crossref
Manpreet Kaur, Rupinder Kaur Sodhi, Vaskuri G.S. Sainaga Jyothi, Veerabomma Haritha Sree, Shubhra, Pankaj Kumar Singh, Neelesh Kumar Mehra, Dharmendra Kumar Khatri, Saurabh Srivastava, Shashi Bala Singh, Jitender Madan & Satish Sardana. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers 289 345 .
Senthil Kumar Subramani, Shailendra Raghuwanshi & Rohit Sharma. 2022. Probiotic Research in Therapeutics. Probiotic Research in Therapeutics 125 141 .
Rishi Gupta & Shailendra Raghuwanshi. 2022. Probiotic Research in Therapeutics. Probiotic Research in Therapeutics 241 260 .
Yeo Jin Kim, Sang Mi Kim, Dae Hyun Jeong, Sang-Kyu Lee, Moo-Eob Ahn & Ohk-Hyun Ryu. (2021) Associations between metabolic syndrome and type of dementia: analysis based on the National Health Insurance Service database of Gangwon province in South Korea. Diabetology & Metabolic Syndrome 13:1.
Crossref
Xiao‐Yu Liu, Ni Zhang, Sheng‐Xiao Zhang & Ping Xu. (2021) Potential new therapeutic target for Alzheimer's disease: Glucagon‐like peptide‐1. European Journal of Neuroscience 54:10, pages 7749-7769.
Crossref
Simona Terzo, Antonella Amato & Flavia Mulè. (2021) From obesity to Alzheimer's disease through insulin resistance. Journal of Diabetes and its Complications 35:11, pages 108026.
Crossref
Yanchao Liu, Shujuan Zhang, Benrong He, Liangkai Chen, Dan Ke, Shi Zhao, Yao Zhang, Wei Wei, Zhipeng Xu, Zihui Xu, Ying Yin, Wen Mo, Yanni Li, Yang Gao, Shihong Li, Weijin Wang, Huiling Yu, Dongqin Wu, Guilin Pi, Tao Jiang, Mingmin Deng, Rui Xiong, Huiyang Lei, Na Tian, Ting He, Fei Sun, Qiuzhi Zhou, Xin Wang, Jinwang Ye, Mengzhu Li, Nan Hu, Guoda Song, Wenju Peng, Chenghong Zheng, Huaqiu Zhang & Jian-Zhi Wang. (2021) Periphery Biomarkers for Objective Diagnosis of Cognitive Decline in Type 2 Diabetes Patients. Frontiers in Cell and Developmental Biology 9.
Crossref
Ling He & Yi Sun. (2021) The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer’s disease, type 2 diabetes, and type 2 diabetes-related Alzheimer’s disease. Metabolic Brain Disease 36:7, pages 1469-1479.
Crossref
Bojlul Bahar, Shalini Kanagasingam, Murtaza M. Tambuwala, Alaa A.A. Aljabali, Stephanie A. Dillon, Saeid Doaei, Richard Welbury, Sasanka S. Chukkapalli & Sim K. Singhrao. (2021) Porphyromonas gingivalis (W83) Infection Induces Alzheimer’s Disease-Like Pathophysiology in Obese and Diabetic Mice. Journal of Alzheimer's Disease 82:3, pages 1259-1275.
Crossref
Sangita Paul, Debarpita Saha & Binukumar BK. (2021) Mitochondrial Dysfunction and Mitophagy Closely Cooperate in Neurological Deficits Associated with Alzheimer’s Disease and Type 2 Diabetes. Molecular Neurobiology 58:8, pages 3677-3691.
Crossref
Bekhzod Olimov, Karshiev Sanjar, Sadia Din, Awaise Ahmad, Anand Paul & Jeonghong Kim. (2021) FU-Net: fast biomedical image segmentation model based on bottleneck convolution layers. Multimedia Systems 27:4, pages 637-650.
Crossref
Zenghui Wei, Jagadish Koya & Sandra E. Reznik. (2021) Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms. Frontiers in Neuroscience 15.
Crossref
Ruta Dekeryte, Zara Franklin, Claire Hull, Lorenzo Croce, Sarah Kamli-Salino, Oliver Helk, Philip A. Hoffmann, Zhixiang Yang, Gernot Riedel, Mirela Delibegovic & Bettina Platt. (2021) The BACE1 inhibitor LY2886721 improves diabetic phenotypes of BACE1 knock-in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1867:7, pages 166149.
Crossref
Fauzia Nazam, Sibhghatulla Shaikh, Nazia Nazam, Abdulaziz Saad Alshahrani, Gulam Mustafa Hasan & Md.Imtaiyaz Hassan. (2021) Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy. Molecular and Cellular Biochemistry 476:7, pages 2739-2752.
Crossref
Adriana Kubis-Kubiak, Benita Wiatrak & Agnieszka Piwowar. (2021) The Impact of High Glucose or Insulin Exposure on S100B Protein Levels, Oxidative and Nitrosative Stress and DNA Damage in Neuron-Like Cells. International Journal of Molecular Sciences 22:11, pages 5526.
Crossref
Jasvinder Singh Bhatti, Kavya Tamarai, Ramesh Kandimalla, Maria Manczak, Xiangling Yin, Bhagavathi Ramasubramanian, Neha Sawant, Jangampalli Adi Pradeepkiran, Murali Vijayan, Subodh Kumar & P. Hemachandra Reddy. (2021) Protective effects of a mitochondria-targeted small peptide SS31 against hyperglycemia-induced mitochondrial abnormalities in the liver tissues of diabetic mice, Tallyho/JngJ mice. Mitochondrion 58, pages 49-58.
Crossref
Chin-Hsiao Tseng. (2021) Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients. Frontiers in Endocrinology 12.
Crossref
Stefanie Schreyer, Nikolaus Berndt, Johannes Eckstein, Michael Mülleder, Shabnam Hemmati-Sadeghi, Charlotte Klein, Basim Abuelnor, Alina Panzel, David Meierhofer, Joachim Spranger, Barbara Steiner & Sebastian Brachs. (2021) Dietary-challenged mice with Alzheimer-like pathology show increased energy expenditure and reduced adipocyte hypertrophy and steatosis. Aging 13:8, pages 10891-10919.
Crossref
Lucas Zangerolamo, Jean F. Vettorazzi, Carina Solon, Gabriela A. Bronczek, Daiane F. Engel, Mirian A. Kurauti, Gabriela M. Soares, Karina S. Rodrigues, Licio A. Velloso, Antonio C. Boschero, Everardo M. Carneiro & Helena C.L. Barbosa. (2021) The bile acid TUDCA improves glucose metabolism in streptozotocin-induced Alzheimer's disease mice model. Molecular and Cellular Endocrinology 521, pages 111116.
Crossref
Yanxian Zhang, Yijing Tang, Dong Zhang, Yonglan Liu, Jian He, Yung Chang & Jie Zheng. (2021) Amyloid cross-seeding between Aβ and hIAPP in relation to the pathogenesis of Alzheimer and type 2 diabetes. Chinese Journal of Chemical Engineering 30, pages 225-235.
Crossref
Jasvinder Singh Bhatti, Kavya Thamarai, Ramesh Kandimalla, Maria Manczak, Xiangling Yin, Subodh Kumar, Murali Vijayan & P. Hemachandra Reddy. (2020) Mitochondria-Targeted Small Peptide, SS31 Ameliorates Diabetes Induced Mitochondrial Dynamics in Male TallyHO/JngJ Mice. Molecular Neurobiology 58:2, pages 795-808.
Crossref
Zhao Zhou, Xin Chen, Huakang Sheng, Xiaolin Shen, Xinxiao Sun, Yajun Yan, Jia Wang & Qipeng Yuan. (2020) Engineering probiotics as living diagnostics and therapeutics for improving human health. Microbial Cell Factories 19:1.
Crossref
Pavithra Mettupalayam Kaliyannan Sundaramoor & Kannan Kilavan Packiam. (2020) In vitro enzyme inhibitory and cytotoxic studies with Evolvulus alsinoides (Linn.) Linn. Leaf extract: a plant from Ayurveda recognized as Dasapushpam for the management of Alzheimer’s disease and diabetes mellitus. BMC Complementary Medicine and Therapies 20:1.
Crossref
Amalia C. Bruni, Livia Bernardi & Carlo Gabelli. (2020) From beta amyloid to altered proteostasis in Alzheimer’s disease. Ageing Research Reviews 64, pages 101126.
Crossref
Md. Sahab Uddin, Md. Tanvir Kabir, Devesh Tewari, Abdullah Al Mamun, George E. Barreto, Simona G. Bungau, May N. Bin-Jumah, Mohamed M. Abdel-Daim & Ghulam Md Ashraf. (2020) Emerging Therapeutic Promise of Ketogenic Diet to Attenuate Neuropathological Alterations in Alzheimer’s Disease. Molecular Neurobiology 57:12, pages 4961-4977.
Crossref
Jong Min Kim, Uk Lee, Jin Yong Kang, Seon Kyeong Park, Jong Cheol Kim & Ho Jin Heo. (2020) Matcha Improves Metabolic Imbalance-Induced Cognitive Dysfunction. Oxidative Medicine and Cellular Longevity 2020, pages 1-19.
Crossref
James Robbins, Oriol Busquets, Ming Tong & Suzanne M. de la Monte. (2020) Dysregulation of Insulin-Linked Metabolic Pathways in Alzheimer’s Disease: Co-Factor Role of Apolipoprotein E ɛ4. Journal of Alzheimer's Disease Reports 4:1, pages 479-493.
Crossref
Arthur T. Kopylov, Olga Papysheva, Iveta Gribova, Galina Kotaysch, Lubov Kharitonova, Tatiana Mayatskaya, Ekaterina Sokerina, Anna L. Kaysheva & Sergey G. Morozov. (2020) Molecular pathophysiology of diabetes mellitus during pregnancy with antenatal complications. Scientific Reports 10:1.
Crossref
Caochong Yan, Yunxiang Zhou, Qiang Chen, Yi Luo, John H. Zhang, Hefeng Huang & Anwen Shao. (2020) Dysfunction of the neurovascular unit in diabetes-related neurodegeneration. Biomedicine & Pharmacotherapy 131, pages 110656.
Crossref
Scott Nugent, Olivier Potvin, Stephen C. Cunnane, Ting-Huei Chen & Simon Duchesne. (2020) Associating Type 2 Diabetes Risk Factor Genes and FDG-PET Brain Metabolism in Normal Aging and Alzheimer’s Disease. Frontiers in Aging Neuroscience 12.
Crossref
Donald J. Alcendor. (2020) Dysregulation of Endothelin-1: Implications for Health Disparities in Alzheimer’s Disease. Journal of Personalized Medicine 10:4, pages 199.
Crossref
Katerina Sobolova, Martina Hrabinova, Vendula Hepnarova, Tomas Kucera, Tereza Kobrlova, Marketa Benkova, Jana Janockova, Rafael Dolezal, Lukas Prchal, Ondrej Benek, Eva Mezeiova, Daniel Jun, Ondrej Soukup & Jan Korabecny. (2020) Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile. European Journal of Medicinal Chemistry 203, pages 112593.
Crossref
Heeyoung Lee & EunYoung Kim. (2020) Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer’s disease. Archives of Pharmacal Research 43:9, pages 932-960.
Crossref
Laura Poupon-Bejuit, Eridan Rocha-Ferreira, Claire Thornton, Henrik Hagberg & Ahad A. Rahim. (2020) Neuroprotective Effects of Diabetes Drugs for the Treatment of Neonatal Hypoxia-Ischemia Encephalopathy. Frontiers in Cellular Neuroscience 14.
Crossref
Sunil Kumar Dubey, K.K. Lakshmi, Kowthavarapu Venkata Krishna, Mukta Agrawal, Gautam Singhvi, Ranendra Narayana Saha, Swarnlata Saraf, Shailendra Saraf, Rahul Shukla & Amit Alexander. (2020) Insulin mediated novel therapies for the treatment of Alzheimer's disease. Life Sciences 249, pages 117540.
Crossref
Esra Ates Bulut, Zehra Yagmur Sahin Alak, Ozge Dokuzlar, Suleyman Emre Kocyigit, Pinar Soysal, Lee Smith & Ahmet Turan Isik. (2020) Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study. Archives of Gerontology and Geriatrics 88, pages 104013.
Crossref
Jeong Su Ha, Jin Yong Kang, Jeong Eun Kang, Seon Kyeong Park, Jong Min Kim, Chul-Woo Kim, Sung-Il Oh, Uk Lee, Dae-Ok Kim & Ho Jin Heo. (2020) Pentacyclic triterpenoid-rich fraction of the Hardy kiwi (Actinidia arguta) improves brain dysfunction in high fat diet-induced obese mice. Scientific Reports 10:1.
Crossref
John M. Clements, Mariana Rosca, Carla Cavallin, Shelby Falkenhagen, Thomas Ittoop, Christina K. Jung, Megan Mazzella, Joseph A. Reed, Megan Schluentz & Caleb VanDyke. (2020) Type 2 Diabetes and Chronic Conditions Disparities in Medicare Beneficiaries in the State of Michigan. The American Journal of the Medical Sciences 359:4, pages 218-225.
Crossref
Kavya Jash, Piyush Gondaliya, Prathibha Kirave, Bhagyashri Kulkarni, Aditya Sunkaria & Kiran Kalia. (2020) Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease. Drug Development Research 81:2, pages 144-164.
Crossref
Zixin Hu, Rong Jiao, Panpan Wang, Yun Zhu, Jinying Zhao, Phil De Jager, David A. Bennett, Li Jin & Momiao Xiong. (2020) Shared Causal Paths underlying Alzheimer’s dementia and Type 2 Diabetes. Scientific Reports 10:1.
Crossref
Ahmad Gholamhosseinian, Roghayeh Abbasalipourkabir, Nasrin Ziamajidi, Mahtab Sayadi & Khatere Sayadi. (2020) The anti-inflammatory effect of omega-3 polyunsaturated fatty acids dramatically decreases by iron in the hippocampus of diabetic rats. Life Sciences 245, pages 117393.
Crossref
Rong Huang, Sai Tian, Haoqiang Zhang, Wenwen Zhu & Shaohua Wang. (2020) Chronic hyperglycemia induces tau hyperphosphorylation by downregulating OGT-involved O-GlcNAcylation in vivo and in vitro. Brain Research Bulletin 156, pages 76-85.
Crossref
Run Liu, Lei Chen, Zhen Wang, Xuewei Zheng, Yan Wang, Hua Li, Mami Noda, Jiankang Liu & Jiangang Long. (2020) Downregulation of the DNA 5-hydroxymethylcytosine is involved in mitochondrial dysfunction and neuronal impairment in high fat diet-induced diabetic mice. Free Radical Biology and Medicine 148, pages 42-51.
Crossref
Chin-Hsiao Tseng. (2020) Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone. Aging and disease 11:3, pages 658.
Crossref
Gema Sanchis-Soler, Juan Tortosa-Martínez, Carmen Manchado-Lopez & Juan Manuel Cortell-Tormo. 2020. Stress and Brain Health: In Clinical Conditions. Stress and Brain Health: In Clinical Conditions 157 193 .
Grażyna Söderbom, Russell Esterline, Jan Oscarsson & Mark P. Mattson. 2020. Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Neurodegenerative Disease Research and Commonalities with Metabolic Diseases. Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Neurodegenerative Disease Research and Commonalities with Metabolic Diseases xv xx .
Richard I. G. Holt. 2020. Diabetes Complications, Comorbidities and Related Disorders. Diabetes Complications, Comorbidities and Related Disorders 687 714 .
Marcos Vinícius Ferreira Silva, Cristina de Mello Gomide Loures, Luan Carlos Vieira Alves, Leonardo Cruz de Souza, Karina Braga Gomes Borges & Maria das Graças Carvalho. (2019) Alzheimer’s disease: risk factors and potentially protective measures. Journal of Biomedical Science 26:1.
Crossref
Bhumsoo Kim, Sarah E. Elzinga, Rosemary E. Henn, Lisa M. McGinley & Eva L. Feldman. (2019) The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease. Neurobiology of Disease 132, pages 104541.
Crossref
Sifan Chen, Ayana Henderson, Michael C. Petriello, Kymberleigh A. Romano, Mary Gearing, Ji Miao, Mareike Schell, Walter J. Sandoval-Espinola, Jiahui Tao, Bingdong Sha, Mark Graham, Rosanne Crooke, Andre Kleinridders, Emily P. Balskus, Federico E. Rey, Andrew J. Morris & Sudha B. Biddinger. (2019) Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction. Cell Metabolism 30:6, pages 1141-1151.e5.
Crossref
Ishita Pal, Madhuparna Roy & Somdatta Ghosh Dey. (2019) Active-site environment of Cu bound amyloid β and amylin peptides. JBIC Journal of Biological Inorganic Chemistry 24:8, pages 1245-1259.
Crossref
Breeya Tailor, Alexander Pilozzi & Xudong Huang. 2019. Alzheimer’s Disease. Alzheimer’s Disease 69 84 .
Kirsty M Porter, Mary Ward, Catherine F Hughes, Maurice O’Kane, Leane Hoey, Adrian McCann, Anne M Molloy, Conal Cunningham, Miriam C Casey, Fergal Tracey, Sean Strain, Kevin McCarroll, Eamon Laird, Alison M Gallagher & Helene McNulty. (2019) Hyperglycemia and Metformin Use Are Associated With B Vitamin Deficiency and Cognitive Dysfunction in Older Adults. The Journal of Clinical Endocrinology & Metabolism 104:10, pages 4837-4847.
Crossref
Maryam Rezazadeh, Hassan Hosseinzadeh, Mohsen Moradi, Behnaz Salek Esfahani, Shahrzad Talebian, Shaho Parvin & Jalal Gharesouran. (2019) Genetic discoveries and advances in late‐onset Alzheimer’s disease. Journal of Cellular Physiology 234:10, pages 16873-16884.
Crossref
Ruta Dekeryte, Claire Hull, Kaja Plucińska, Shakil Khan, Sarah Kamli-Salino, Nimesh Mody, Nicola Morrice, Chris McLaughlin, Victor Gault, Bettina Platt & Mirela Delibegovic. (2019) Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice. Biochemical Pharmacology 166, pages 222-230.
Crossref
Anna Rorbach-Dolata & Agnieszka Piwowar. (2019) Neurometabolic Evidence Supporting the Hypothesis of Increased Incidence of Type 3 Diabetes Mellitus in the 21st Century. BioMed Research International 2019, pages 1-8.
Crossref
Fan Hong, Shijia Pan, Yuan Guo, Pengfei Xu & Yonggong Zhai. (2019) PPARs as Nuclear Receptors for Nutrient and Energy Metabolism. Molecules 24:14, pages 2545.
Crossref
Qian Shi, Shuqian Liu, Vivian A Fonseca, Tina K Thethi & Lizheng Shi. (2019) Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus. BMJ Open 9:7, pages e024954.
Crossref
Liang Yu & Lin Gao. (2019) Human Pathway-Based Disease Network. IEEE/ACM Transactions on Computational Biology and Bioinformatics 16:4, pages 1240-1249.
Crossref
George A. Edwards III, Nazaret Gamez, Gabriel Escobedo Jr.Olivia Calderon & Ines Moreno-Gonzalez. (2019) Modifiable Risk Factors for Alzheimer’s Disease. Frontiers in Aging Neuroscience 11.
Crossref
Qun Wang, Yan Shen, Yongmin Chen & Xiaohua Li. (2019) Impacts of nurse-led clinic and nurse-led prescription on hemoglobin A1c control in type 2 diabetes. Medicine 98:23, pages e15971.
Crossref
Chin-Hsiao Tseng. (2019) Rosiglitazone has a neutral effect on the risk of dementia in type 2 diabetes patients. Aging 11:9, pages 2724-2734.
Crossref
Sarah Patrick, Rachel Corrigan, John Grizzanti, Megan Mey, Jeff Blair, Merce Pallas, Antonio Camins, Hyoung-gon Lee & Gemma Casadesus. (2019) Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer’s Disease Are Associated with Oxidative Stress Regulation Mechanisms. Journal of Alzheimer's Disease 69:1, pages 157-168.
Crossref
Martin H. Lundqvist, Kristina Almby, Niclas Abrahamsson & Jan W. Eriksson. (2019) Is the Brain a Key Player in Glucose Regulation and Development of Type 2 Diabetes?. Frontiers in Physiology 10.
Crossref
Suzanne M. de la Monte, Ming Tong, Lori A. Daiello & Brian R. Ott. (2019) Early-Stage Alzheimer’s Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways. Journal of Alzheimer's Disease 68:2, pages 657-668.
Crossref
Kalkena Sivanesam & Niels Andersen. (2019) Pre-structured hydrophobic peptide β-strands: A universal amyloid trap?. Archives of Biochemistry and Biophysics 664, pages 51-61.
Crossref
Aditi Wagle, Su Hui Seong, Srijan Shrestha, Hyun Ah Jung & Jae Sue Choi. (2019) Korean Thistle (Cirsium japonicum var. maackii (Maxim.) Matsum.): A Potential Dietary Supplement against Diabetes and Alzheimer’s Disease. Molecules 24:3, pages 649.
Crossref
Rongzi Li, Yuxian Zhang, Suhail Rasool, Thangiah Geetha & Jeganathan Ramesh Babu. (2019) Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity 2019, pages 1-25.
Crossref
Tseng Chin-Hsiao. (2019) Metformin and the Risk of Dementia in Type 2 Diabetes Patients. Aging and disease 10:1, pages 37.
Crossref
Martina Holubová, Lucie Hrubá, Andrea Popelová, Michal Bencze, Veronika Pražienková, Simon Gengler, Helena Kratochvílová, Martin Haluzík, Blanka Železná, Jaroslav Kuneš, Christian Hölscher & Lenka Maletínská. (2019) Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology. Neuropharmacology 144, pages 377-387.
Crossref
Yu-Li Chen, Shih-Feng Weng, Chwen-Yi Yang, Jhi-Joung Wang & Kai-Jen Tien. (2019) Diabetic ketoacidosis further increases risk of Alzheimer’s disease in patients with type 2 diabetes. Diabetes Research and Clinical Practice 147, pages 55-61.
Crossref
Nicola Salvi. 2019. Intrinsically Disordered Proteins. Intrinsically Disordered Proteins 257 274 .
Suzanne M. de la Monte. 2019. Diabetes Mellitus. Diabetes Mellitus 45 83 .
Richard I. G. Holt. 2019. Diabetes Complications, Comorbidities and Related Disorders. Diabetes Complications, Comorbidities and Related Disorders 1 28 .
Matthew G. Iadanza, Matthew P. Jackson, Eric W. Hewitt, Neil A. Ranson & Sheena E. Radford. (2018) A new era for understanding amyloid structures and disease. Nature Reviews Molecular Cell Biology 19:12, pages 755-773.
Crossref
Amir Hadi, Makan Pourmasoumi, Hamed Mohammadi, Michael Symonds & Maryam Miraghajani. (2018) The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials. Complementary Therapies in Medicine 41, pages 311-319.
Crossref
Kim E. Innes, Terry Kit Selfe, Kathleen Brundage, Caitlin Montgomery, Sijin Wen, Sahiti Kandati, Hannah Bowles, Dharma Singh Khalsa & Zenzi Huysmans. (2018) Effects of Meditation and Music-Listening on Blood Biomarkers of Cellular Aging and Alzheimer’s Disease in Adults with Subjective Cognitive Decline: An Exploratory Randomized Clinical Trial. Journal of Alzheimer's Disease 66:3, pages 947-970.
Crossref
Krzysztof Drygalski, Eliza Fereniec, Krzysztof Koryciński, Andrzej Chomentowski, Aleksandra Kiełczewska, Cezary Odrzygóźdź & Beata Modzelewska. (2018) Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials. Experimental Gerontology 113, pages 36-47.
Crossref
Marianna E. Jung & Robert T. Mallet. (2018) Intermittent hypoxia training: Powerful, non-invasive cerebroprotection against ethanol withdrawal excitotoxicity. Respiratory Physiology & Neurobiology 256, pages 67-78.
Crossref
Chin-Hsiao Tseng. (2018) Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis. Journal of Clinical Medicine 7:10, pages 306.
Crossref
Jyotiska Chaudhuri, Yasmin Bains, Sanjib Guha, Arnold Kahn, David Hall, Neelanjan Bose, Alejandro Gugliucci & Pankaj Kapahi. (2018) The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality. Cell Metabolism 28:3, pages 337-352.
Crossref
Xu-Nian Wu, Ya-Dan Huang, Jin-Xuan Li, Yan-Fa Yu, Zhou Qian, Chen Zhang, Yinuo Wu & Hai-Bin Luo. (2018) Structure-based design, synthesis, and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors. Acta Pharmaceutica Sinica B 8:4, pages 615-628.
Crossref
Shreyasi Chatterjee & Amritpal Mudher. (2018) Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits. Frontiers in Neuroscience 12.
Crossref
Die Pu, Yuxing Zhao, Jinliang Chen, Yue sun, Ankang Lv, Shiyu Zhu, Cheng Luo, Kexiang Zhao & Qian Xiao. (2018) Protective Effects of Sulforaphane on Cognitive Impairments and AD-like Lesions in Diabetic Mice are Associated with the Upregulation of Nrf2 Transcription Activity. Neuroscience 381, pages 35-45.
Crossref
Jeddidiah W. D. Griffin, Ying Liu, Patrick C. Bradshaw & Kesheng Wang. (2018) In Silico Preliminary Association of Ammonia Metabolism Genes GLS, CPS1, and GLUL with Risk of Alzheimer’s Disease, Major Depressive Disorder, and Type 2 Diabetes. Journal of Molecular Neuroscience 64:3, pages 385-396.
Crossref
S. Alford, D. Patel, N. Perakakis & C. S. Mantzoros. (2018) Obesity as a risk factor for Alzheimer's disease: weighing the evidence. Obesity Reviews 19:2, pages 269-280.
Crossref
Tatsuya MAEKAWA, Takeshi OHTA & Shinichi KUME. (2018) Pathophysiological abnormalities in the brains of Spontaneously Diabetic Torii-<i>Lepr <sup>fa</sup></i> (SDT fatty) rats, a novel type 2 diabetic model. Journal of Veterinary Medical Science 80:9, pages 1385-1391.
Crossref
Hong Zheng, Qi Zhou, Yao Du, Chen Li, Pengtao Xu, Li Lin, Jian Xiao & Hongchang Gao. (2018) The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:1, pages 263-273.
Crossref
Richard I. G. Holt. 2018. Diabetes Complications, Comorbidities and Related Disorders. Diabetes Complications, Comorbidities and Related Disorders 689 716 .
Richard I. G. Holt. 2018. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment 1 27 .
Simon Vann Jones & Ilias Kounatidis. (2017) Nuclear Factor-Kappa B and Alzheimer Disease, Unifying Genetic and Environmental Risk Factors from Cell to Humans. Frontiers in Immunology 8.
Crossref
Marta Sochocka, Breno Satler Diniz & Jerzy Leszek. (2016) Inflammatory Response in the CNS: Friend or Foe?. Molecular Neurobiology 54:10, pages 8071-8089.
Crossref
Shazi Shakil. (2017) Molecular Interaction of Anti‐Diabetic Drugs With Acetylcholinesterase and Sodium Glucose Co‐Transporter 2. Journal of Cellular Biochemistry 118:11, pages 3855-3865.
Crossref
Moon K. Song, David S. Bischoff, Albert M. Song, Koichi Uyemura & Dean T. Yamaguchi. (2017) Metabolic relationship between diabetes and Alzheimer's Disease affected by Cyclo(His-Pro) plus zinc treatment. BBA Clinical 7, pages 41-54.
Crossref
Agnieszka Śmieszek, Zuzanna Stręk, Katarzyna Kornicka, Jakub Grzesiak, Christine Weiss & Krzysztof Marycz. (2017) Antioxidant and Anti-Senescence Effect of Metformin on Mouse Olfactory Ensheathing Cells (mOECs) May Be Associated with Increased Brain-Derived Neurotrophic Factor Levels—An Ex Vivo Study. International Journal of Molecular Sciences 18:4, pages 872.
Crossref
Teresa Ponce-Lopez, Enrique Hong, Manuel Abascal-Díaz & Alfredo Meneses. (2017) Role of GSK3<i>β</i> and PP2A on Regulation of Tau Phosphorylation in Hippocampus and Memory Impairment in ICV-STZ Animal Model of Alzheimer’s Disease. Advances in Alzheimer's Disease 06:01, pages 13-31.
Crossref
Chong Gao & Jiangang Shen. 2017. Neurobiology of Chinese Herb Medicine. Neurobiology of Chinese Herb Medicine 117 147 .
D.Y. Hu, C.Y. Hu & E.C. Corum. 2017. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders 267 285 .
Suzanne M. de la Monte. (2016) Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer’s Disease. Drugs 77:1, pages 47-65.
Crossref
Giuseppe Caruso, Donatella A. Distefano, Paolo Parlascino, Claudia G. Fresta, Giuseppe Lazzarino, Susan M. Lunte & Vincenzo G. Nicoletti. (2016) Receptor-mediated toxicity of human amylin fragment aggregated by short- and long-term incubations with copper ions. Molecular and Cellular Biochemistry 425:1-2, pages 85-93.
Crossref
Quanri Liu, Yu An, Huanling Yu, Yanhui Lu, Lingli Feng, Chao Wang & Rong Xiao. (2016) Relationship between oxysterols and mild cognitive impairment in the elderly: a case–control study. Lipids in Health and Disease 15:1.
Crossref
Meng H. Tan, Hussain Alquraini, Kara Mizokami-Stout & Mark MacEachern. (2016) Metformin. Endocrinology and Metabolism Clinics of North America 45:4, pages 819-843.
Crossref
E. M. Ribe & S. Lovestone. (2016) Insulin signalling in Alzheimer′s disease and diabetes: from epidemiology to molecular links. Journal of Internal Medicine 280:5, pages 430-442.
Crossref
Siobhan M. Hoscheidt, Erika J. Starks, Jennifer M. Oh, Henrik Zetterberg, Kaj Blennow, Rachel A. Krause, Carey E. Gleason, Luigi Puglielli, Craig S. Atwood, Cynthia M. Carlsson, Sanjay Asthana, Sterling C. Johnson & Barbara B. Bendlin. (2016) Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults. Journal of Alzheimer's Disease 52:4, pages 1373-1383.
Crossref
Shih-Yin Chen, Yuan-Man Hsu, Ying-Ju Lin, Yu-Chuen Huang, Chao-Jung Chen, Wei-De Lin, Wen-Lin Liao, Yng-Tay Chen, Wei-Yong Lin, Yu-Huei Liu, Jai-Sing Yang, Jinn-Chyuan Sheu & Fuu-Jen Tsai. (2016) Current concepts regarding developmental mechanisms in diabetic retinopathy in Taiwan. BioMedicine 6:2.
Crossref
Khyati Mittal & Deepshikha Pande Katare. (2016) Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 10:2, pages S144-S149.
Crossref
Bin Chen, Ying Teng, Xingguang Zhang, Xiaofeng Lv & Yanling Yin. (2016) Metformin Alleviated A β -Induced Apoptosis via the Suppression of JNK MAPK Signaling Pathway in Cultured Hippocampal Neurons . BioMed Research International 2016, pages 1-8.
Crossref
Hanna Wehr & Małgorzata Bednarska-Makaruk. (2016) Vitamin D and cognition. Postępy Psychiatrii i Neurologii 25:1, pages 49-53.
Crossref
Poornima Venkat, Michael Chopp & Jieli Chen. (2015) Models and mechanisms of vascular dementia. Experimental Neurology 272, pages 97-108.
Crossref
Mingzhen Zhang, Rundong Hu, Hong Chen, Yung Chang, Jie Ma, Guizhao Liang, Jingyan Mi, Yaru Wang & Jie Zheng. (2015) Polymorphic cross-seeding amyloid assemblies of amyloid-β and human islet amyloid polypeptide. Physical Chemistry Chemical Physics 17:35, pages 23245-23256.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.